FIELD: medicine; hematology.
SUBSTANCE: activity of glucose-6-phosphatedehydrogenase (G6PDG) and NADP-depending glutamate dehydrogenase (NADP DHG) is determined by bioluminescent test in patients with acute leucosis, before chemotherapy. When G6PDG is 10.02 to 66.51 mcU and NADP DHG is within 84.27 to 257.39 mcU, the hemorrhagic complications are predicted, and when G6PDG is 0.01 to 4.45 mcU and NADP DHG is within 0.01 to 52.86 mcU, absence of hemorrhagic complications are predicted.
EFFECT: method provides the increased precision of prognosis of hemorrhagic complications following chemotherapy in patients with acute leucosis.
4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING INFECTIOUS COMPLICATIONS AFTER CHEMOTHERAPY IN PATIENTS WITH ACUTE LEUKOSIS | 2005 |
|
RU2315305C2 |
| METHOD FOR PREDICTION OF RECURRENCES IN PATIENTS WITH ACUTE LEUKEMIA | 2012 |
|
RU2478206C1 |
| METHOD OF PREDICTING DEVELOPMENT OF ACUTE ENDOMETRIOSIS AFTER MEDICAL ABORTION | 2010 |
|
RU2452377C1 |
| METHOD FOR PREDICTION OF INTERFERON SENSITIVITY IN PATIENTS SUFFERING RENAL CELL CARCINOMA | 2010 |
|
RU2437101C1 |
| METHOD FOR PREDICTION OF PROGRESSION OF VENTRICULAR ARRHYTHMIA IN PATIENTS WITH POSTINFARCTION CARDIOSCLEROSIS | 2014 |
|
RU2554808C1 |
| METHOD FOR PREDICTION OF STATE OF NEWBORNS OF WOMEN WITH GESTOSIS OF VARIOUS SEVERITY LEVELS | 2009 |
|
RU2421732C2 |
| METHOD OF PREDICTING DEVELOPMENT OF TERMINAL STAGE IN PATIENTS WITH CHRONIC MYELOLEUKAEMIA | 2013 |
|
RU2550944C2 |
| METHOD FOR PREDICTING THE OUTCOME OF ACUTE DESTRUCTIVE PANCREATITIS | 2016 |
|
RU2651030C1 |
| METHOD FOR PREDICTION OF CARDIOVASCULAR COMPLICATIONS IN PATIENTS SUFFERING ISCHEMIC HEART DISEASE FOLLOWING CORONARY ARTERY BYPASS SURGERY | 2011 |
|
RU2466395C1 |
| METHOD OF PREDICTING RECURRENT CEREBROVASCULAR COMPLICATIONS IN PATIENTS WITH HYPERTENSION IN COMBINATION WITH ISCHEMIC HEART DISEASE IN ACUTE PERIOD OF ISCHEMIC STROKE | 2010 |
|
RU2425640C1 |
